Research programme: MUC1-targeted anticancer therapies - Genzyme Oncology
Alternative Names: IPB-01; IPB-02Latest Information Update: 11 Feb 2008
At a glance
- Originator Genzyme Oncology
- Class Monoclonal antibodies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer